DexTech Medical ABXSAT:DEX +2.91%32 Gross Margin % is 0.00% as of Mar. 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 735 Biotechnology companies, DexTech Medical AB ranks worse than 136054.29% on this metric.
The historical rank and industry rank for DexTech Medical AB's Gross Margin % or its related term are showing as below:
During the past 13 years, the highestGross Margin % of DexTech Medical AB was 1853.80%. The lowest was 1853.80%. And the median was 1853.80%.
XSAT:DEX's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.9 * Ranked among companies with meaningful Gross Margin % only.
DexTech Medical AB had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for DexTech Medical AB was 0.00% per year.
DexTech Medical AB (XSAT:DEX) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DexTech Medical AB had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
DexTech Medical AB Gross Margin % Related Terms
DexTech Medical AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for DexTech Medical AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:DEX vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, DexTech Medical AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DexTech Medical AB Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where DexTech Medical AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DexTech Medical AB (XSAT:DEX) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on DexTech Medical AB and its competitors. Over the past decade, DexTech Medical AB's Gross Margin % has ranged from 1,853.80 to 1,853.80. According to the industry distribution chart, DexTech Medical AB ranks #999999 out of 735 companies in the Biotechnology industry.
Is DexTech Medical AB's Gross Margin % too high?
DexTech Medical AB's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 1,853.80 to a high of 1,853.80. Based on the distribution chart, DexTech Medical AB ranks #999999 out of 735 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, DexTech Medical AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, DexTech Medical AB ranks #999999 out of 735 companies for Gross Margin %. This places DexTech Medical AB in the lower half of its industry. The industry median Gross Margin % is 60.90. Historically, DexTech Medical AB's own Gross Margin % has ranged from 1,853.80 to 1,853.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on DexTech Medical AB and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DexTech Medical AB's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. DexTech Medical AB's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
32GF Score
Get the complete analysis for XSAT:DEX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:DEX has been successfully added to your 
